Skip to main content

Table 3 Biomarker performance detection of “PanCancer” panel (FOXA1me, RARβ2me and RASSF1Ame) in ccfDNA

From: Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel

 

PanCancer

Sensitivity %

64.3

Specificity %

69.8

Accuracy %

66.4

Positive likelihood ratio (LR+)

2.3

Negative likelihood ratio (LR-)

0.52